Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Interventions to Improve Patient Adherence to Hepatitis C Treatment: Comparative Effectiveness [Internet].

Sun X, Patnode CD, Williams C, Senger CA, Kapka TJ, Whitlock EP.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Dec.

2.
3.

Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Lozano P, Henrikson NB, Dunn J, Morrison CC, Nguyen M, Blasi PR, Anderson ML, Whitlock E.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug.

4.

Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C.

Hauser G, Awad T, Brok J, Thorlund K, Štimac D, Mabrouk M, Gluud C, Gluud LL.

Cochrane Database Syst Rev. 2014 Feb 28;(2):CD005441. Review.

PMID:
24585509
6.

Lipid Screening in Childhood for Detection of Multifactorial Dyslipidemia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Lozano P, Henrikson NB, Morrison CC, Dunn J, Nguyen M, Blasi P, Whitlock EP.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug.

7.

The clinical effectiveness and cost-effectiveness of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people: a systematic review and economic evaluation.

Hartwell D, Cooper K, Frampton GK, Baxter L, Loveman E.

Health Technol Assess. 2014 Oct;18(65):i-xxii, 1-202. doi: 10.3310/hta18650. Review.

8.

Screening and Interventions for Childhood Overweight [Internet].

Whitlock EP, Williams SB, Gold R, Smith P, Shipman S.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Jul.

9.

Screening for Chronic Obstructive Pulmonary Disease: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Guirguis-Blake JM, Senger CA, Webber EM, Mularski R, Whitlock EP.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Apr.

10.

Low-Dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Henderson JT, Whitlock EP, O'Conner E, Senger CA, Thompson JH, Rowland MG.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr.

11.

Nitazoxanide for chronic hepatitis C.

Nikolova K, Gluud C, Grevstad B, Jakobsen JC.

Cochrane Database Syst Rev. 2014 Apr 6;(4):CD009182. doi: 10.1002/14651858.CD009182.pub2. Review.

PMID:
24706397
12.

Behavioural interventions for type 2 diabetes: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2009;9(21):1-45. Epub 2009 Oct 1.

13.

Treatment for Hepatitis C Virus Infection in Adults [Internet].

Chou R, Hartung D, Rahman B, Wasson N, Cottrell E, Fu R.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Nov.

14.

Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients.

Katz LH, Goldvaser H, Gafter-Gvili A, Tur-Kaspa R.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD008516. doi: 10.1002/14651858.CD008516.pub2. Review.

PMID:
22972122
15.

Screening for Skin Cancer in Adults: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Wernli KJ, Henrikson NB, Morrison CC, Nguyen M, Pocobelli G, Whitlock EP.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jul.

16.

Weight loss interventions for chronic asthma.

Adeniyi FB, Young T.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD009339. doi: 10.1002/14651858.CD009339.pub2. Review.

PMID:
22786526
17.

Aminoadamantanes versus other antiviral drugs for chronic hepatitis C.

Lamers MH, Broekman M, Drenth JP, Gluud C.

Cochrane Database Syst Rev. 2014 Jun 17;(6):CD011132. doi: 10.1002/14651858.CD011132.pub2. Review.

PMID:
24937404
18.

Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Service Task Force [Internet].

Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, Shah K.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jan.

19.

Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.

Shepherd J, Brodin H, Cave C, Waugh N, Price A, Gabbay J.

Health Technol Assess. 2004 Oct;8(39):iii-iv, 1-125. Review.

20.

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.

Items per page

Supplemental Content

Write to the Help Desk